Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/−bevacizumab for the first-line treatment of non-squamous NSCLC: a matching-adjusted indirect comparison
Pembrolizumab plus chemotherapy for metastatic NSCLC with programmed cell death ligand 1 tumor proportion score <1%: pooled analysis of outcomes after five years of follow-up
Thromboprophylaxis with original enoxaparin in oncology patients
Inferior vena cava resection and reconstruction with falciform ligament graft for leiomyosarcoma. Case reportAuthors: Kvasivka O.O. Moiseienko A.B. Pareniuk R.Y. Pepenin I.O.... Дата: 2025-02-17
Reconstruction of the mandible using CAD/CAM technologies in patients with oral cancer and primary bone tumorsAuthor:Burtyn O.V. Дата: 2025-02-14
CLL in the context of evidence-based medicine: how do international guidelines align with Ukrainian practice?Authors: Kryachok I.A. Tytorenko I.B. Moroz Y.V. Т. 14, №4 (56)
Midazolam in modern anesthesiology and intensive careAuthors: Lisnyy I.I. Zakalska K.A. Т. 14, №4 (56)
Conducting mobilization courses and apheresis of CD34+. Experience of the Nonprofit Organization National Cancer InstituteAuthors: Kryachok I.A. Raіnyk K.P. Shokun N.V. Burtna A.S. Т. 14, №4 (56)
Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trialТ. 14, №4 (56)
KEYNOTE-006 study: results of 10-year follow-up of pembrolizumab versus ipilimumab in advanced melanomaТ. 14, №4 (56)
A Multidisciplinary Approach to Breast Cancer Treatment in Historical Perspective
Use of artificial intelligence in medicine, surgery, dentistry, and oncologyAuthors: Svintsitskyi A.V. Klymova V.V. Sendetskyi S.S. Т. 14, №4 (56)
A rare form of renal cell cancer metastasis to the minor salivary gland: a clinical caseAuthors: Antoniv R.R. Kostyshyn I.D. Girna G.A. Boyko V.V.... Т. 14, №4 (56)
Cost minimization analysis of neoadjuvant treatment of luminal B HER2/neu-negative breast cancer: chemotherapy versus hormone therapyAuthors: Artemenko M.V. Bondarenko I.M. Zavizion V.F. Avierin D.I. Т. 14, №4 (56)
